Does Neoadjuvant Chemotherapy for Carcinoma in the Thoracic Esophagus increase Postoperative Morbidity?
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-08-10
著者
-
Okuma Toshiyuki
First Department Of Surgery Kumamoto University School Of Medicine
-
MORI Takeshi
First Department of Surgery, Kumamoto University School of Medicine
-
YOSHIOKA Masakazu
First Department of Surgery, Kumamoto University School of Medicine
-
Yoshioka Masakazu
First Department Of Surgery Kumamoto University School Of Medicine
-
Kitamura Nobuo
First Department Of Surgery Kumamoto University School Of Medicine
-
Tabira Yoichi
First Department Of Surgery Kumamoto University School Of Medicine
-
OKUMA Toshitada
First Department of Surgery Kumamoto University School of Medicine
-
KONDO Keiichiro
First Department of Surgery Kumamoto University School of Medicine
-
TANAKA Makoto
First Department of Surgery Kumamoto University School of Medicine
-
NAKANO Kan-yu
First Department of Surgery Kumamoto University School of Medicine
-
Mori Takeshi
First Department Of Surgery Kumamoto University School Of Medicine
-
KITAMURA Nobuo
First Department of Surgery, Kumamoto University School of Medicine
関連論文
- Expression of constitutively activated EGFRvlll in non-small cell lung cancer
- Does Neoadjuvant Chemotherapy for Carcinoma in the Thoracic Esophagus increase Postoperative Morbidity?
- Disease-free Survival for 9 Years After Liver Resection for Stage IV Gallbladder Cancer : Report of a Case
- Subcutaneous Metastases After Curative Resection for Pancreatic Carcinoma : A Case Report and Review of the Literature
- Mediastinal Growing Teratoma Syndrome
- Functional, Metabolic, and Histological Changes of Vascular Tissues after Warm Ischemia
- Changes in Respiratory Condition after Thymectomy for Patients with Myasthenia Gravis
- Effects of Recombinant Tissue-type Plasminogen Activator on Life-threatening Acute Pulmonary Thromboembolism in a Canine Model : A Comparative Study of E6010 and Alteplase
- PP-1014 IS LOCALLY APPLIED TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AN IDEAL ANTITHROMBOTIC AGENT IN SMALL ATERIAL RECONSTRUCTIVE PROCEDURES?
- Altered Plasma Antigen Levels of Tissue Factor Pathway Inhibitor During Open-Heart Surgery
- Direct Expiratory Gas Analysis after Hypothermic Cardiopulmonary Bypass
- Recovery from Metabolic Impairments after Hypothermic Cardiopulmonary Bypass : Postoperative Changes in Arterial-Venous Carbon Dioxide Tension Difference
- The Effects of Cardiopulmonary Bypass on Postoperative Oxygen Metabolism
- Patch Reconstruction of the Mitral Annulus for Active Infective Endocarditis with Annular Abscess
- Resuscitation and Evaluation of Non-beating Hearts Obtained from Asphyxiated Dogs via Autoperfusing Heart-Lung Circuit